Auto-immune Hepatitis

1

Review clinical trials related to Auto-immune Hepatitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?

Evaluate the proportion of seronegative auto-immune hepatitis and a possible relationship with the severity of the disease. Criteria of severity will be defined by corticodependance, corticoresistance and a severe form of the disease at diagnosis (cirrhosis or fulminant hepatitis). In case of predominant seronegative forms, other auto-antibodies related to this auto-immue hepatitis will be searched.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Centre Hospitalier Universitaire de la GuadeloupeUpdated: Jan 7, 2025Locations: 2
Eligibility criteria

- Any patient over 18 years old [+3]

Patient under 18 years old [+10]